GlassScriptPhysician profile
James Gordon Arnold
NPI 1215933809
$553.83
in general payments reported to CMS, 2019-2025
16 companies · $94.12 in 2025
The $94.12 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $42.35 · 2021: $143 · 2022: $14.20 · 2023: $19.25 · 2024: $57.62 · 2025: $94.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $161.72 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.34 | 2019 | |
| Lupin INC. | $39.27 | 2019-2021 | |
| Evofem Biosciences, INC. | $37.36 | 2024-2025 | Solosec, Phexx, Phexxi |
| Hologic Sales and Service, LLC | $33.76 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Pacira Pharmaceuticals Incorporated | $27.20 | 2019 | |
| Biogen, INC. | $27.05 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $26.01 | 2025 | Myfembree |
| Insulet Corporation | $23.89 | 2024 | Omnipod |
| Abbott Laboratories | $23.00 | 2019 | |
| Mayne Pharma Commercial LLC | $19.25 | 2023 | |
| Organon LLC | $15.51 | 2024 | |
| Mission Pharmacal Company | $15.06 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.20 | 2022 | |
| Daiichi Sankyo INC. | $12.34 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.